Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

ANTISTREPTOLYSIN - ANVISA Registration 10345162467

Access comprehensive regulatory information for ANTISTREPTOLYSIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10345162467 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including BIOSYSTEMS S.A., KOVALENT DO BRASIL LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10345162467
Registration Details
ANVISA Registration Number: 10345162467
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Atellica CH Antiestreptolisina-O_3 (ASO_3)
Risk Class II

Registration Details

10345162467

25351216654202307

01449930000190

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

May 15, 2023

VIGENTE

09/18/2025 19:00:01